Literature DB >> 18156250

Function of a mycobacterial major facilitator superfamily pump requires a membrane-associated lipoprotein.

Mary F Farrow1, Eric J Rubin.   

Abstract

The lprG-Rv1410c operon is critical for the survival of Mycobacterium tuberculosis during infection, but very little is known about the functions of its proteins. LprG is a lipoprotein, and Rv1410c encodes the major facilitator superfamily small molecule transporter P55. P55 likely exports small molecules outside of the bacterial cell, but the function of LprG is unclear. A deletion of the homologous operon in Mycobacterium smegmatis is more susceptible to ethidium bromide, and drug resistance is restored by the intact operon from M. tuberculosis. The multidrug resistance pump inhibitor reserpine inhibits resistance to ethidium bromide in both wild-type M. smegmatis and the complemented mutant, suggesting that P55-mediated transport is responsible for drug resistance and that ethidium bromide is a novel substrate for P55. In addition to hypersensitivity to ethidium bromide, cells that lack the lprG-Rv1410c operon display abnormal colony morphology and are defective for sliding motility, properties that suggest an alteration of cell wall composition. Strikingly, both ethidium bromide transport and normal cell surface properties require functional P55 and LprG, as neither alone is sufficient to restore function to the deletion mutant. Thus, P55 requires the cell surface lipoprotein for normal function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18156250      PMCID: PMC2258667          DOI: 10.1128/JB.01046-07

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  15 in total

1.  LppX is a lipoprotein required for the translocation of phthiocerol dimycocerosates to the surface of Mycobacterium tuberculosis.

Authors:  Gerlind Sulzenbacher; Stéphane Canaan; Yann Bordat; Olivier Neyrolles; Gustavo Stadthagen; Véronique Roig-Zamboni; Jean Rauzier; Damien Maurin; Françoise Laval; Mamadou Daffé; Christian Cambillau; Brigitte Gicquel; Yves Bourne; Mary Jackson
Journal:  EMBO J       Date:  2006-03-16       Impact factor: 11.598

Review 2.  Proton-dependent multidrug efflux systems.

Authors:  I T Paulsen; M H Brown; R A Skurray
Journal:  Microbiol Rev       Date:  1996-12

3.  Sliding motility in mycobacteria.

Authors:  A Martínez; S Torello; R Kolter
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

4.  Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice.

Authors:  J S Cox; B Chen; M McNeil; W R Jacobs
Journal:  Nature       Date:  1999-11-04       Impact factor: 49.962

5.  The gene encoding P27 lipoprotein and a putative antibiotic-resistance gene form an operon in Mycobacterium tuberculosis and Mycobacterium bovis.

Authors:  F Bigi; A Alito; M I Romano; M Zumarraga; K Caimi; A Cataldi
Journal:  Microbiology       Date:  2000-04       Impact factor: 2.777

6.  A novel 27 kDa lipoprotein antigen from Mycobacterium bovis.

Authors:  F Bigi; C Espitia; A Alito; M Zumarraga; M I Romano; S Cravero; A Cataldi
Journal:  Microbiology (Reading)       Date:  1997-11       Impact factor: 2.777

7.  Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis.

Authors:  L R Camacho; D Ensergueix; E Perez; B Gicquel; C Guilhot
Journal:  Mol Microbiol       Date:  1999-10       Impact factor: 3.501

Review 8.  Major facilitator superfamily.

Authors:  S S Pao; I T Paulsen; M H Saier
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

9.  The knockout of the lprG-Rv1410 operon produces strong attenuation of Mycobacterium tuberculosis.

Authors:  Fabiana Bigi; Andrea Gioffré; Laura Klepp; María de la Paz Santangelo; Alicia Alito; Karina Caimi; Virginia Meikle; Martín Zumárraga; Oscar Taboga; María I Romano; Angel Cataldi
Journal:  Microbes Infect       Date:  2004-02       Impact factor: 2.700

10.  Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing.

Authors:  Adam J Gehring; Karen M Dobos; John T Belisle; Clifford V Harding; W Henry Boom
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

View more
  30 in total

1.  The mycobacterial P55 efflux pump is required for optimal growth on cholesterol.

Authors:  Santiago Ramón-García; Gordon R Stewart; Zhao Kun Hui; William W Mohn; Charles J Thompson
Journal:  Virulence       Date:  2015       Impact factor: 5.882

2.  Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.

Authors:  Santiago Ramón-García; Carlos Martín; Charles J Thompson; José A Aínsa
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

Review 3.  Virulence factors of the Mycobacterium tuberculosis complex.

Authors:  Marina A Forrellad; Laura I Klepp; Andrea Gioffré; Julia Sabio y García; Hector R Morbidoni; María de la Paz Santangelo; Angel A Cataldi; Fabiana Bigi
Journal:  Virulence       Date:  2012-10-17       Impact factor: 5.882

4.  A Screen for Protein-Protein Interactions in Live Mycobacteria Reveals a Functional Link between the Virulence-Associated Lipid Transporter LprG and the Mycolyltransferase Antigen 85A.

Authors:  Megan H Touchette; Erik R Van Vlack; Lu Bai; Jia Kim; Armand B Cognetta; Mary L Previti; Keriann M Backus; Dwight W Martin; Benjamin F Cravatt; Jessica C Seeliger
Journal:  ACS Infect Dis       Date:  2017-03-21       Impact factor: 5.084

5.  Surface proteome of "Mycobacterium avium subsp. hominissuis" during the early stages of macrophage infection.

Authors:  Michael McNamara; Shin-Cheng Tzeng; Claudia Maier; Li Zhang; Luiz E Bermudez
Journal:  Infect Immun       Date:  2012-03-05       Impact factor: 3.441

6.  Dimethylaminophenyl Hydrazides as Inhibitors of the Lipid Transport Protein LprG in Mycobacteria.

Authors:  Lu Bai; Lia A Parkin; Hong Zhang; Rebecca Shum; Mary L Previti; Jessica C Seeliger
Journal:  ACS Infect Dis       Date:  2020-03-03       Impact factor: 5.084

7.  A novel copper-responsive regulon in Mycobacterium tuberculosis.

Authors:  Richard A Festa; Marcus B Jones; Susan Butler-Wu; Daniel Sinsimer; Russell Gerads; William R Bishai; Scott N Peterson; K Heran Darwin
Journal:  Mol Microbiol       Date:  2010-10-29       Impact factor: 3.501

8.  Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis.

Authors:  Olga Danilchanka; Claudia Mailaender; Michael Niederweis
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

9.  Mycobacterium tuberculosis lipoprotein LprG (Rv1411c) binds triacylated glycolipid agonists of Toll-like receptor 2.

Authors:  Michael G Drage; Han-Chun Tsai; Nicole D Pecora; Tan-Yun Cheng; Ahmad R Arida; Supriya Shukla; Roxana E Rojas; Chetan Seshadri; D Branch Moody; W Henry Boom; James C Sacchettini; Clifford V Harding
Journal:  Nat Struct Mol Biol       Date:  2010-08-08       Impact factor: 15.369

10.  The efflux pump inhibitor timcodar improves the potency of antimycobacterial agents.

Authors:  Trudy H Grossman; Carolyn M Shoen; Steven M Jones; Peter L Jones; Michael H Cynamon; Christopher P Locher
Journal:  Antimicrob Agents Chemother       Date:  2014-12-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.